Los Angeles Capital Management
ZYME icon

Los Angeles Capital Management’s Zymeworks ZYME Stock Holding History

Los Angeles Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$995K Buy
39,750
+39,363
+10,171% +$931K ﹤0.01% 683
2025
Q4 		$7.4K Buy
+387
New +$8.44K ﹤0.01% 2183

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Los Angeles Capital Management's ZYME Position: Q1 2026 in Review

Los Angeles Capital Management increased its Zymeworks (ZYME) stake by 10,171% in Q1 2026, buying an estimated $931K and bringing the position to 39,750 shares worth $995K. The position accounts for ﹤0.01% of the portfolio, ranked #683.

Los Angeles Capital Management first reported a position in ZYME in Q4 2025 and has held it in 2 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Los Angeles Capital Management held 39,750 shares of Zymeworks worth $995K as of Q1 2026.
  • Los Angeles Capital Management bought 39,363 Zymeworks shares in Q1 2026, an estimated $931K.
  • Zymeworks made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #683 holding.
  • Los Angeles Capital Management first reported a position in Zymeworks in Q4 2025 and has held it in 2 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.